News roundup [abridged versions appear in the paper journal]

WHO tries to tackle problem of counterfeit medicines in Asia

BMJ 2003; 327 doi: 10.1136/bmj.327.7424.1126-a (Published 13 November 2003)
Cite this as: BMJ 2003;327:1126.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Stephen Pincock
  1. London

    Experts from the World Health Organization were in Hanoi this week to discuss ways of tackling the problem of counterfeit medicines with officials from countries in Asia's Mekong delta region.

    WHO sees the problem of fake or substandard medicines as a serious public health threat in the “greater Mekong subregion,” which includes Vietnam, the Lao People's Democratic Republic, Cambodia, China, Myanmar, and Thailand.

    It hopes that the meetings will kick-start efforts to raise awareness among decision makers, health professionals, and the general public and to strengthen inspection and post-marketing surveillance.

    Recent WHO estimates suggest that Cambodia has about 2800 illegal medicine sellers and 1000 unregistered medicines …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular